Synovis Life Technologies (NASDAQ:SYNO) will hold a conference call on Wednesday, August 27 at 11:00 am ET to discuss the third quarter earnings for 2008. The call will be hosted by president and chief executive officer Richard Kramp and chief financial officer Brett Reynolds. A webcast of the presentation will be available on the Investor Relations section of the company’s website at synovislife.com.
Synovis Life Technologies, Inc. is a diversified medical device company engaged in developing, manufacturing, marketing and selling products for the surgical and interventional treatment of disease.
The two segments of the Company were the surgical business and the interventional business. The surgical business develops, manufactures, markets and sells implantable biomaterial products, devices for microsurgery and surgical tools, all designed to reduce risk and/or facilitate critical surgeries. The interventional business developed, engineered, prototyped and manufactured coils, helices, stylets, guidewires and other complex micro-wire, polymer and micro-machined metal components and assemblies used in or with implantable or minimally invasive devices for cardiac rhythm management, neurostimulation, vascular and other procedures.
In January 2008, it announced that it had closed on the previously announced sale of its interventional business to Heraeus Vadnais and related entities.
Read more Business News on The Global Market Directory.
About The Global Market Directory (TheGMD)
TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals. The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies.
The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.
Create your profile on The Global Market Directory.